Table 5.
Template B1B B2 | Product distribution +C/+T/+A/+G | Template B1B B2 | Product distribution +C/+T/+A/+G | Template B1B B2 | Product distribution +C/+T/+A/+G | Template B1B B2 | Product distribution +C/+T/+A/+G |
AAA | 0/ > 99/0/0 | AAC | 0/ > 99/0/0 | AAG | 0/ > 99/0/0 | AAT | 0/ > 99/0/0 |
ACA | 1/1/5/93 | ACC | 2/10/4/84 | ACG | 0/10/6/84 | ACT | 0/2/2/96 |
AGA | 86/7/5/2 | AGC | 84/8/6/2 | AGG | 83/8/8/1 | AGT | 91/6/3/0 |
ATA | 0/7/93/0 | ATC | 0/5/94/1 | ATG | 0/10/90/0 | ATT | 0/3/97/0 |
CAA | 0/ > 99/0/0 | CAC | 0/98/0/2 | CAG | 0/93/7/0 | CAT | 0/ > 99/0/0 |
CCA | 0/2/0/98 | CCC | 2/11/8/79 | CCG | 3/15/10/72 | CCT | 0/0/3/97 |
CGA | 92/5/2/1 | CGC | 87/8/4/1 | CGG | 78/15/7/0 | CGT | 91/7/2/0 |
CTA | 0/5/95/0 | CTC | 0/9/90/1 | CTG | 0/11/89/0 | CTT | 0/3/97/0 |
GAA | 0/ > 99/0/0 | GAC | 0/ > 99/0/0 | GAG | 2/98/0/0 | GAT | 0/ > 99/0/0 |
GCA | 0/4/3/93 | GCC | 1/3/1/95 | GCG | 4/9/6/81 | GCT | 0/0/2/98 |
GGA | 84/6/9/1 | GGC | 73/10/15/3 | GGG | 75/9/16/0 | GGT | 87/6/5/2 |
GTA | 0/4/96/0 | GTC | 0/3/97/0 | GTG | 2/6/91/1 | GTT | 0/1/99/0 |
TAA | 0/97/3/0 | TAC | 0/ > 99/0/0 | TAG | 0/94/6/0 | TAT | 0/96/4/0 |
TCA | 1/4/2/93 | TCC | 0/7/7/86 | TCG | 3/5/5/87 | TCT | 0/2/2/96 |
TGA | 90/6/4/0 | TGC | 81/11/7/1 | TGG | 92/4/3/1 | TGT | 93/4/2/1 |
TTA | 0/2/98/0 | TTC | 0/5/93/2 | TTG | 0/0/ > 99/0 | TTT | 0/0/ > 99/0 |
Conditions: Hepes buffer pH 8.9 (200 mM), 3.6 mM dGMP-OAt, 7.2 mM dCMP-OAt, 10.8 mM dAMP-OAt, 22 mM TMP-OAt, 54 μM template and downstream-binding oligonucleotide, 36 μM primer, 20 °C. Conversion of the primers > 99% at the end of the assay in all cases.